Previous close | 0.5100 |
Open | 0.5100 |
Bid | 0.3000 |
Ask | 1.5200 |
Strike | 530.00 |
Expiry date | 2024-07-19 |
Day's range | 0.5100 - 0.5100 |
Contract range | N/A |
Volume | |
Open interest | 39 |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Amazon reported strong first-quarter results, with revenue and operating income ahead of expectations. The company delivered operating income of $15.3 billion, above consensus of $11.3 billion, while reporting better-than-expected growth in both Amazon Web Services (+17.2% year over year versus Street +15%) and advertising (+24.3% Y/Y versus Street +23.5%). Amazon has now reported operating income above the high end of its guidance range for five consecutive quarters, and the company has a number of drivers for further margin expansion in place, including continued cost efficiencies within its fulfillment network as well as the ongoing mix shift toward higher-margin AWS and advertising revenue.
Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged" by interim data from the phase II study on obesity candidate MariTide.